Your browser doesn't support javascript.
loading
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity.
Ji, Linong; Jiang, Hongwei; Cheng, Zhifeng; Qiu, Wei; Liao, Lin; Zhang, Yawei; Li, Xiaoli; Pang, Shuguang; Zhang, Lihui; Chen, Liming; Yang, Tao; Li, Yan; Qu, Shen; Wen, Jie; Gu, Jieyu; Deng, Huan; Wang, Yanqi; Li, Li; Han-Zhang, Han; Ma, Qingyang; Qian, Lei.
Afiliação
  • Ji L; Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China. jiln@bjmu.edu.cn.
  • Jiang H; The First Affiliated Hospital and Clinical Medicine College, Henan University of Science and Technology, Luoyang, China.
  • Cheng Z; Department of Endocrinology and Metabolism, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Qiu W; Department of Endocrinology, Huzhou Central Hospital, Huzhou, China.
  • Liao L; Department of Endocrinology, Shandong Province Qianfoshan Hospital, Jinan, China.
  • Zhang Y; Department of Endocrinology, Pingxiang People's Hospital, Pingxiang, China.
  • Li X; Department of Endocrinology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
  • Pang S; Department of Endocrinology, Jinan Central Hospital, Jinan, China.
  • Zhang L; Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Chen L; NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
  • Yang T; Department of Endocrinology, Jiangsu Province Hospital, Nanjing, China.
  • Li Y; Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Qu S; Department of Endocrinology, Shanghai Tenth People's Hospital of Tong Ji University, Shanghai, China.
  • Wen J; Innovent Biologics, Inc., Suzhou, China.
  • Gu J; Innovent Biologics, Inc., Suzhou, China.
  • Deng H; Innovent Biologics, Inc., Suzhou, China.
  • Wang Y; Innovent Biologics, Inc., Suzhou, China.
  • Li L; Innovent Biologics, Inc., Suzhou, China.
  • Han-Zhang H; Innovent Biologics, Inc., Suzhou, China.
  • Ma Q; Innovent Biologics, Inc., Suzhou, China.
  • Qian L; Innovent Biologics, Inc., Suzhou, China. cnradium@126.com.
Nat Commun ; 14(1): 8289, 2023 Dec 14.
Article em En | MEDLINE | ID: mdl-38092790

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Sobrepeso Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Sobrepeso Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article